Biomarkers: Technologies and Global Markets

Publisher Name :
Date: 10-Mar-2021
No. of pages: 216

Report Scope:

BCC Research's new report, Biomarkers: Technologies and Global Markets, provides a comprehensive analysis of the biomarkers market in a global context, including market forecasts and sales through 2025. The report analyzes the market, segmenting it into various product offerings (i.e., instruments, consumables [reagents, kits and panels], services and software). Segmentation also provides analysis by popular technology type (genomics, proteomics and metabolomics, imaging and bioinformatics).

<>This study surveys the biomarker market by therapeutic area (cancer, cardiovascular and metabolic diseases, infectious diseases, neurodegenerative diseases, autoimmune diseases and others. End users include academic institutes, pharma and biotechnology companies, clinical research organizations, hospitals and diagnostics. Geographic regions include North America, Europe and Emerging markets. Emerging markets include countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, etc.

This report features new product developments and patents that are boosting global growth in this market.

This report provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on changing market trends, market players and leading products. This chapter also covers mergers and acquisitions and other collaborations or partnerships that are expected to shape the industry.

Strengths, weaknesses, threats and opportunities are expected to play a role in the diagnostic biomarkers market. These are evaluated in detail.

The scope of the report excludes in vitro diagnostic products and regulatory aspects. Digital biomarkers are not covered in this report.

Report Includes:

- 48 data tables and 25 additional tables

- An updated review and current landscape of the global biomarkers market

- Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025

- Estimation of market size and market potential for global biomarkers market, and corresponding market share analysis by product type, technology type, therapeutic area, end user and geographic region for each market segment

- Latest information on market opportunities and drivers, industry structure, regulatory frameworks, clinical trials and technological updates which are affecting the overall market growth

- Identification of the leading biotechnology companies poised to introduce products during the forecast period, their impact on the face of the competitive environment and research priorities

- Encompassing details of major types of biomarkers and their use in clinical trial assessment, drug discovery and development, and therapeutics

- Review of patents issued for biomarker technologies and deep dive of the patent data by year, technology type, application, company, assignee and applicant country

- Profile description of the of major market players, including Abbott Laboratories Ltd., Bayer AG, Bio-Rad Laboratories Inc., Canon Medical Corp., and Luminex Corp.

Summary:

Biomarkers, the biological indicators of health and disease, have come a long way, from being used as simple measurements of clinical diagnosis, to becoming essential tools in the clinical space and drug discovery and development. The utility of biomarkers has been expanding over the last couple of decades, due to the potential for predicting disease diagnosis and prognosis, treatment response, pharmacokinetics of drugs and monitoring therapy. During the COVID-19 pandemic, boosted R&D for novel diagnostics led to the approval of many biomarker-based diagnostic tests for early and rapid detection of the SARS-CoV-2 virus.

Pharmaceutical and biopharmaceutical drug developers struggle to overcome escalating cost barriers and high drug attrition rates in late-stage clinical trials. Biomarkers are promising tools to address drug development challenges. offering the prediction of drug toxicity and efficacy in early stages. The 21st Century Act allowed the Food and Drug Administration (FDA) to publish guidelines for Biomarker Qualification for use in drug development programs, paving the way for biomarker inclusion into drug development through either the drug approval process or the Biomarker Qualification Program.

Biomarkers are extremely useful in clinical trials, increasingly used to identify populations for a study, monitor therapeutic response and identify side effects. There is an emerging market of clinical research organizations (CROs) carrying out clinical trial recruitment and other services, while expanding technical expertise in bioanalytical and biomarker development. This enables pharmaceutical clients access to biomarker discovery and development.

The global biomarkers market is growing at a significant pace, driven by an explosion of publications and clinical trials. Enhanced analytical methods and the development of new, sophisticated and sensitive multiplex methods in gene expression analysis, proteomics, metabolomics and transcriptomics bring huge momentum to this market. The development of multi-biomarker assays, novel immunoassays and multi-modal imaging and mass spectrometry methods further drive market growth.

Collaborations and strategic partnerships, mergers and acquisitions and other deals between private and public players are on the rise. Companies are strengthening technical know-how and expanding product portfolios in order to offer enhanced services and new offerings to the biomarker research community. Precision medicine, particularly in the field of cancer, has contributed tremendously to an interest in biomarkers, with growing adoption of biomarkers in companion diagnostics and selecting targeted patient populations for high-value drugs. Other therapeutic areas, such as cardiovascular, neurodegenerative and autoimmune diseases are getting noticeable attention in biomarker research.

Challenges for this market, remain in the form of disparity in biomarker definitions at an international level and lack of any defined regulatory guidance for use in R&D. There is still a need to develop sensitive and robust methods of analysis for low concentration analytes via methods that can be validated. Lack of skilled manpower and the high cost of technology are other challenging factors.

Positive approaches in biomarker research, effective dialogue and collaborations between all stakeholders is expected to address challenges and take this market forward in coming years.

Biomarkers: Technologies and Global Markets

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Key Highlights
Chapter 3 Market and Technology Background
Definitions of Biomarkers
Classification of Biomarkers
Examples of Biomarkers
Surrogate Biomarkers/Endpoints
Types of Biomarkers
Molecular Biomarkers
Imaging Biomarkers
Biomarker Discovery, Verification and Validation
Biomarker Discovery and Development
Biomarker Verification
Biomarker Validation
Clinical Implementation
Biomarker Qualification
Technologies Used in Biomarker Analysis
Genomics
Proteomics
Metabolomics
Imaging
Bioinformatics
Applications of Biomarkers
Diagnostics, Therapeutics and Disease Monitoring
Drug Discovery and Development
Clinical Trials
Personalized Medicine
Chapter 4 Market Breakdown by Product Type
Market by Biomarker Product Type
Market Overview
Market Revenue
Market Share
Market for Biomarker Products by Region
Market Shares
Instruments
Consumables
Services
Software
Chapter 5 Market Breakdown by Technology Type
Biomarker Market by Technology Type
Market Overview
Market Revenue
Market Share
Genomics
Proteomics
Metabolomics
Imaging
Bioinformatics
Chapter 6 Market Breakdown by Therapeutic Area
Market by Therapeutic Area
Market Overview
Market Revenue
Market Share
Cancer
Cardiovascular and Metabolic Diseases
Infectious Diseases
Neurodegenerative Diseases
Autoimmune Diseases
Other Diseases
Chapter 7 Market Breakdown by End User
Market by Biomarker End User
Market Overview
Market Revenue
Market Share
Academic Institutes
Pharma and Biotechnology Companies
Clinical Research Organizations (CROs)
Hospitals and Diagnostics
Chapter 8 Industry Structure
Industry Trends
Collaborations and Partnerships
License Agreements
Mergers and Acquisitions
Leading Manufacturers/Suppliers of Biomarkers Technologies
Genomics
Proteomics
Metabolomics
Imaging
Bioinformatics
Chapter 9 Clinical Trials
Clinical Trials by Therapeutic Area
Clinical Trials by Study Status
Clinical Trials by Study Phase
Clinical Trials of Studies including Children
Clinical Trials by Country
Clinical Trials by Sponsor
Chapter 10 Patent Analysis
Patents on Biomarkers
Case Studies
Case Study: Association for Molecular Pathology v. Myriad Genetics Inc.
Case Study: Roche Molecular Systems Inc. v. Cepheid
Patent Analysis
Patents by Year
Patents by Type
Patents by Application
Patents by Company
Patents, by Country
Patents by Type of Assignee
Chapter 11 Analysis of Market Opportunities
Strengths of the Biomarker Market
Rising Incidence of Diseases
Drug Development Costs and Failures
Advances in Omics and Imaging Technologies
Support from Regulatory Agencies
Collaborations and Partnerships
Challenges in the Biomarker Market
Technological Challenges
Regulatory Challenges
Requirement of Skilled Labor
High Development Cost of Biomarkers
Reimbursement Challenges
Opportunities in the Biomarker Market
Emerging Markets
Personalized Medicine
Innovation in Technology
Funding and Research Initiatives
Threats to the Biomarker Market
Competition
Regulatory and Reimbursement Challenges
COVID-19 Pandemic
Chapter 12 Company Profiles
10X GENOMICS
ABBOTT LABORATORIES LTD.
ABCAM PLC
AGILENT TECHNOLOGIES INC.
BAYER AG
BECKMAN COULTER LIFE SCIENCES
BECTON DICKINSON & CO.
BIOLEGEND
BIO-RAD LABORATORIES INC.
BIO-TECHNE CORP.
BRUKER CORP.
CANON MEDICAL SYSTEMS CORP.
CEPHEID
CREATIVE PROTEOMICS
CUBRESA INC.
CYTIVA
DANAHER CORP.
FUJIFILM VISUAL SONICS INC.
GE HEALTHCARE
F HOFFMANN-LA ROCHE AG
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES (IDT)
JEOL LTD.
KONINKLIJKE PHILIPS N.V.
LANTHEUS MEDICAL IMAGING INC.
LECO CORP.
LEICA BIOSYSTEMS
LUMINEX CORP.
METABOLON INC.
MILLIPORE SIGMA
MOLECULAR DEVICES
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES INC.
PERKINELMER INC.
PROMEGA CORP.
QIAGEN N.V.
QUANTERIX CORP.
SCIEX
SIEMENS HEALTHINEER AG
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.
Chapter 13 Appendix: Abbreviations/Acronyms

List of Tables
Summary Table : Global Market for Biomarkers, by Technology, Through 2025
Table 1 : Different Categories of Biomarkers
Table 2 : Examples of Biomarkers
Table 3 : Different Types of ELISAs
Table 4 : Global Market for Biomarkers, by Product Type, Through 2025
Table 5 : Global Market Shares of Biomarkers, by Product Type, 2019
Table 6 : Global Market for Biomarkers, by Region, Through 2025
Table 7 : Global Market Shares of Biomarkers, by Region, 2019
Table 8 : Global Market for Biomarker Instruments, by Region, Through 2025
Table 9 : Global Market for Biomarker Consumables, by Region, Through 2025
Table 10 : Global Market for Biomarker Services, by Region, Through 2025
Table 11 : Global Market for Biomarker Software, by Region, Through 2025
Table 12 : Global Market for Biomarkers, by Technology Type, Through 2025
Table 13 : Global Market Shares of Biomarkers, by Technology Type, 2019
Table 14 : Global Market for Genomics Biomarkers, by Region, Through 2025
Table 15 : Global Market for Proteomics Biomarkers, by Region, Through 2025
Table 16 : Global Market for Metabolomics Biomarkers, by Region, Through 2025
Table 17 : Global Market for Imaging Biomarkers, by Region, Through 2025
Table 18 : Global Market for Bioinformatics in Biomarkers, by Region, Through 2025
Table 19 : Global Market for Biomarkers, by Therapeutic Area, Through 2025
Table 20 : Global Market Shares of Biomarkers, by Therapeutic Area, 2019
Table 21 : Global Market for Cancer Biomarkers, by Region, Through 2025
Table 22 : Global Market for Cardiovascular and Metabolic Disease Biomarkers, by Region, Through 2025
Table 23 : Global and U.S. Prevalence, Common Infectious Diseases
Table 24 : Global Market for Infectious Disease Biomarkers, by Region, Through 2025
Table 25 : Global Market for Neurodegenerative Disease Biomarkers, by Region, Through 2025
Table 26 : Global Market for Autoimmune Disease Biomarkers, by Region, Through 2025
Table 27 : Biomarkers for Other Diseases
Table 28 : Global Market for Biomarkers for Other Diseases, by Region, Through 2025
Table 29 : Global Market for Biomarkers, by End User, Through 2025
Table 30 : Global Market Shares of Biomarkers, by End User, 2019
Table 31 : Global Market for Biomarkers in Academic Institutes, by Region, Through 2025
Table 32 : Global Market for Biomarkers in Pharma and Biotechnology, by Region, Through 2025
Table 33 : Global Market for Biomarkers in CROs, by Region, Through 2025
Table 34 : Global Market for Biomarkers in Hospitals and Diagnostics, by Region, Through 2025
Table 35 : Alliances in Global Biomarker Market, by Year, 2018-2020
Table 36 : Biomarker-Focused Consortia, 2002-2017
Table 37 : Collaborations/Partnerships in the Global Biomarker Market, 2018-January 2021
Table 38 : Licensing Agreements in the Global Biomarker Market, 2018-January 2021
Table 39 : Mergers and Acquisitions in the Global Biomarker Market, 2018-January 2021
Table 40 : Leading Manufacturers/Suppliers of Genomic Technologies, 2019
Table 41 : Global Market Shares of Leading Manufacturers/Suppliers of Genomic Technologies, 2019
Table 42 : Leading Manufacturers/Suppliers of Proteomic Technologies, 2019
Table 43 : Global Market Shares of Leading Manufacturers/Suppliers of Proteomics Technologies, 2019
Table 44 : Leading Manufacturers/Suppliers, Metabolomic Technologies, 2019
Table 45 : Global Market Shares of Leading Manufacturers/Suppliers of Metabolomic Technologies, 2019
Table 46 : Leading Manufacturers/Suppliers, Imaging Technologies, 2019
Table 47 : Global Market Shares of Leading Manufacturers/Suppliers of Imaging Technologies, 2019
Table 48 : Leading Manufacturers/Suppliers of Bioinformatics Technologies, 2019
Table 49 : Global Market Shares of Leading Manufacturers/Suppliers of Bioinformatics Technologies, 2019
Table 50 : Clinical Trials in Biomarkers, by Therapeutic Area, 2018-2020
Table 51 : Clinical Trials in Biomarkers, by Study Status, 2018-2020
Table 52 : Clinical Trials in Biomarkers, by Phase of the Study, 2018-2020
Table 53 : Clinical Trials in Biomarkers, Studies including Children, 2018-2020
Table 54 : Clinical Trials in Biomarkers, by Country, 2018-2020
Table 55 : Clinical Trials in Biomarkers, by Sponsor, 2018-2020
Table 56 : Representative Patents in Biomarkers, 2018-December 15, 2020
Table 57 : Patents Issued for Biomarkers, by Year, 2018-December 15, 2020
Table 58 : Patents Issued for Biomarkers, by Type, 2018-December 15, 2020
Table 59 : Patents Issued for Biomarkers, by Application, 2018-December 15, 2020
Table 60 : Patents Issued for Biomarkers, by Company, 2018-December 15, 2020
Table 61 : Patents Issued for Biomarkers, by Country, 2018-December 15, 2020
Table 62 : Patents Issued for Biomarkers, by Type of Assignee, 2018-December 15, 2020
Table 63 : Biomarkers with Letters of Support from the EMA, 2018-2020
Table 64 : Companion Diagnostics and Approved Drugs, 2017-2020
Table 65 : FoundationOne CDx Approved Indications
Table 66 : Abbott Laboratories: Biomarker Clinical Trials
Table 67 : Bayer: Biomarker Clinical Trials
Table 68 : Bio-Rad Laboratories: Biomarker Clinical Trials
Table 69 : GE Healthcare: Biomarker Clinical Trials
Table 70 : F Hoffmann-La Roche: Biomarker Clinical Trials
Table 71 : Millipore-Sigma: Biomarker Clinical Trials
Table 72 : Abbreviations in Biomarker Technologies and Global Markets Report

List of Figures
Summary Figure : Global Market for Biomarkers, by Technology, 2018-2025
Figure 1 : Different Categories of Biomarkers
Figure 2 : Molecular and Imaging Biomarkers
Figure 3 : Biomarker Discovery, Verification and Validation
Figure 4 : Biomarker Qualification Process
Figure 5 : Global Market for Biomarkers, by Product Type, 2018-2025
Figure 6 : Global Market Shares of Biomarkers, by Product Type, 2019
Figure 7 : Global Market for Biomarkers, by Region, 2018-2025
Figure 8 : Global Market Shares of Biomarkers, by Region, 2019
Figure 9 : Global Market for Biomarker Instruments, by Region, 2018-2025
Figure 10 : Global Market for Biomarker Consumables, by Region, 2018-2025
Figure 11 : Global Market for Biomarker Services, by Region, 2018-2025
Figure 12 : Global Market for Biomarker Software, by Region, 2018-2025
Figure 13 : Global Market for Biomarkers, by Technology Type, 2018-2025
Figure 14 : Global Market Shares of Biomarkers, by Technology Type, 2019
Figure 15 : Global Market for Genomics Biomarkers, by Region, 2018-2025
Figure 16 : Global Market for Proteomics Biomarkers, by Region, 2018-2025
Figure 17 : Global Market for Metabolomics Biomarkers, by Region, 2018-2025
Figure 18 : Global Market for Imaging Biomarkers, by Region, 2018-2025
Figure 19 : Global Market for Bioinformatics in Biomarkers, by Region, 2018-2025
Figure 20 : Global Market for Biomarkers, by Therapeutic Area, 2018-2025
Figure 21 : Global Market Shares of Biomarkers, by Therapeutic Area, 2019
Figure 22 : Global Market for Cancer Biomarkers, by Region, 2018-2025
Figure 23 : Global Market for Cardiovascular and Metabolic Disease Biomarkers, by Region, 2018-2025
Figure 24 : Global Market for Infectious Disease Biomarkers, by Region, 2018-2025
Figure 25 : Global Market for Neurodegenerative Disease Biomarkers, by Region, 2018-2025
Figure 26 : Global Market for Autoimmune Disease Biomarkers, by Region, 2018-2025
Figure 27 : Global Market for Biomarkers for Other Diseases, by Region, 2018-2025
Figure 28 : Global Market for Biomarkers, by End User, 2018-2025
Figure 29 : Global Market Shares of Biomarkers, by End User, 2019
Figure 30 : Global Market for Biomarkers in Academic Institutes, by Region, 2018-2025
Figure 31 : Global Market for Biomarkers in Pharma and Biotechnology, by Region, 2018-2025
Figure 32 : Global Market for Biomarkers in CROs, by Region, 2018-2025
Figure 33 : Global Market for Biomarkers in Hospitals and Diagnostics, by Region, 2018-2025
Figure 34 : Global Market Shares of Leading Manufacturers/Suppliers of Genomic Technologies, 2019
Figure 35 : Global Market Shares of Leading Manufacturers/Suppliers of Proteomics Technologies, 2019
Figure 36 : Global Market Shares of Leading Manufacturers/Suppliers of Metabolomic Technologies, 2019
Figure 37 : Global Market Shares of Leading Manufacturers/Suppliers of Imaging Technologies, 2019
Figure 38 : Global Market Shares of Leading Manufacturers/Suppliers of Bioinformatic Technologies, 2019
Figure 39 : Clinical Trials in Biomarkers, by Therapeutic Area, 2018-2020
Figure 40 : Clinical Trials in Biomarkers, by Study Status, 2018-2020
Figure 41 : Clinical Trials in Biomarkers, by Phase of the Study, 2018-2020
Figure 42 : Clinical Trials in Biomarkers, Studies including Children, 2018-2020
Figure 43 : Patents Issued for Biomarkers, by Year, 2018-December 15, 2020
Figure 44 : Patents Issued for Biomarkers, by Type, 2018-December 15, 2020
Figure 45 : Patents Issued for Biomarkers, by Application, 2018-December 15, 2020
Figure 46 : Patents Issued for Biomarkers, by Country, 2018-December 15, 2020
Figure 47 : Patents Issued for Biomarkers, by Type of Assignee, 2018-December 15, 2020
Figure 48 : Global Market for Biomarker SWOT Analysis
  • Global Biomarkers Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period. The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
  • Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Biomarker (Medicine) market: According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years. Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Commercializing Biom......
  • Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Biomarkers market: According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
  • Global Biomarker Technology Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Quanterix - Bio-Rad Laboratories - Epigenomics - Agilent Technologies - Johnson & Johnson - Qiagen - Roche Ho......
  • Global Renal Biomarkers Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 99
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Diagnostics - F. Hoffmann-La Roche - Beckman Coulter - Siemens Healthcare Diagnostics - Thermo Fisher Scientific - Astute Medical - Bio......
  • Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Central Nervous System (CNS) Biomarkers market: According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. An overview of the global market for central nervous system (CNS) biomarke......
  • Global Cancer Biomarker Market Research Report 2023
    Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 109
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Bio-Rad Laboratories - Roche Diagnostics - Qiagen - Illumina - GE Healthcare - Agilent Technologies - Biomér......
  • Biomarker Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs